however, there was a small increase in CTX [MD: +0.04 g/L (95% CI: 0.01 to 0.07)] ( Weight loss attributable to the GLP1Ra interventions included in the meta-analysis by Kim et al
For example, exendin-based GLP-1 analogues have an alanine to glutamic acid substitution in the second position [40]
Practice Pearl(s) The dosing regimen of glucagon-like peptide-1 (GLP-1) agonists is characterized by careful initiation and titration to ensure optimal glycemic control while minimizing potential adverse effects
Which Medicine Is Best for You
Hector Perez, MD, lead bariatric surgeon at Renew Bariatrics and an advisor at Bariatric Reports, told Healthline that when it comes to weight loss, its too early to call survodutide a game-changer. [W]hile the reported weight loss number is impressive, we already have very strong performers in this category, he said
However, GR also is involved in increasing blood glucose (Undesirable in diabetic patients), meaning this needs to be offset by corresponding decreases in blood glucose via GLP1R